Bullish
Cantor Fitzgerald raises Ultragenyx stock price target on therapy outlook By Investing.com
Cantor Fitzgerald has increased its price target for Ultragenyx Pharma (NASDAQ: RARE) to $96 from $84, maintaining an Overweight rating. This adjustme...